[{"Assets_0_Q2_USD":424177000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":31523000.0,"NetIncomeLoss_1_Q2_USD":2777000.0,"NetIncomeLoss_2_Q2_USD":5027000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":11789000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":11748000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":11679000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":11634000.0,"StockholdersEquity_0_Q2_USD":185110000.0,"EarningsPerShareBasic_2_Q2_USD":0.43,"EarningsPerShareBasic_1_Q2_USD":0.24,"EarningsPerShareDiluted_1_Q2_USD":0.23,"EarningsPerShareDiluted_2_Q2_USD":0.42,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":47268000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":93751000.0,"Ticker":"ANIP","CIK":"1023024","name":"ANI PHARMACEUTICALS INC","OfficialName":"ANI Pharmaceuticals Inc.","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"569805985.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20180807"}]